Results 341 to 350 of about 236,761 (380)
Sodium-Glucose Cotransporter-2 Inhibitors in Liver Cirrhosis: A Systematic Review of Their Role in Ascites Management, Slowing Disease Progression, and Safety. [PDF]
Dhoop S+10 more
europepmc +1 more source
Fluid Overload in Cardiorenal Medicine: From Bench to Bedside.
Cobo Marcos M+2 more
europepmc +1 more source
Examining Symptom Management and Quality of Life of Loop Diuretic-Induced Overactive Bladder Among Heart Failure Patients: Physician and Patient Perspectives. [PDF]
Pan X+4 more
europepmc +1 more source
Identification and Validation of Urea Transporter B Inhibitor from <i>Apium graveolens</i> L. Seeds In Vitro and In Silico. [PDF]
Chen G+12 more
europepmc +1 more source
Expanding the role of PoCUS in tailoring diuretic strategies for congestion management in critical care. [PDF]
Romero-González G+4 more
europepmc +1 more source
Ultrafiltration in Elderly Patients with Type 1 Cardiorenal Syndrome: Efficacy and Safety Outcomes.
Xu L, Wang Z, Sun L, Liu B, Li H.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
British Journal of Hospital Medicine, 2009
Diuretics enhance the rate of excretion of sodium ions (Na+) and water. They are usually taken in the morning so that diuresis does not intrude upon sleep. Diuretics are divided into groups based on their mechanism and site of action: loop, thiazide, potassium-sparing, osmotic, mercurial and carbonic anhydrase inhibitors (Figure 1).
Mah, Baig, R, Shakur, D, Scott
+8 more sources
Diuretics enhance the rate of excretion of sodium ions (Na+) and water. They are usually taken in the morning so that diuresis does not intrude upon sleep. Diuretics are divided into groups based on their mechanism and site of action: loop, thiazide, potassium-sparing, osmotic, mercurial and carbonic anhydrase inhibitors (Figure 1).
Mah, Baig, R, Shakur, D, Scott
+8 more sources